NYSE:KVUE Kenvue Q3 2025 Prepared Remarks Earnings Report $17.82 +0.21 (+1.16%) Closing price 03:59 PM EasternExtended Trading$17.68 -0.14 (-0.76%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Kenvue EPS ResultsActual EPS$0.28Consensus EPS $0.27Beat/MissBeat by +$0.01One Year Ago EPS$0.28Kenvue Revenue ResultsActual Revenue$3.76 billionExpected Revenue$3.83 billionBeat/MissMissed by -$64.88 millionYoY Revenue Growth-3.50%Kenvue Announcement DetailsQuarterQ3 2025 Prepared RemarksDate11/3/2025TimeBefore Market OpensConference Call DateMonday, November 3, 2025Conference Call Time6:00AM ETUpcoming EarningsKenvue's Q3 2026 earnings is estimated for Monday, November 2, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 6, 2026 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsEarnings Release(8-K) Kenvue Earnings HeadlinesMarket Chatter: Kimberly-Clark Offers Concessions for EU Approval of $40 Billion Kenvue DealSeptember 23 at 12:42 PM | finance.yahoo.comEU extends review of Kimberly-Clark’s $40B Kenvue dealSeptember 23 at 12:42 PM | seekingalpha.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.September 25 at 1:00 AM | InvestorPlace (Ad)Kimberly-Clark offers remedies in bid for EU approval of Kenvue dealSeptember 23 at 5:34 AM | reuters.com5 Beaten-Down Dividend Kings Ready to Roar Back in 2027 (One Yields Over 5%)September 22 at 9:12 AM | 247wallst.comKenvue Inc's Dividend AnalysisSeptember 21, 2026 | finance.yahoo.comSee More Kenvue Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Kenvue? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kenvue and other key companies, straight to your email. Email Address About KenvueKenvue (NYSE:KVUE) is a global consumer health company that develops, markets and sells products designed to support everyday health and personal care. Its portfolio spans over-the-counter medicines, skin health and beauty, essential health products, and baby and family care. The company’s brands include Tylenol, Motrin, Zyrtec and Benadryl in self-care; Neutrogena, Aveeno and Clean & Clear in skin health and beauty; Listerine in oral care; and Johnson’s and Band-Aid in baby care and essential health. Kenvue products are sold through retailers, pharmacies, e-commerce channels and other distribution networks in markets around the world. Kenvue was formed from the consumer health business of Johnson & Johnson and became a publicly traded company on the New York Stock Exchange in 2023. Johnson & Johnson completed the separation of Kenvue as an independent company in 2024. Kenvue is headquartered in Skillman, New Jersey, and is led by Chief Executive Officer Thibaut Mongon.View Kenvue ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks3 Space Stocks to Watch as SpaceX Reshapes the Launch MarketOil May Be Stronger Than It Looks—And Diamondback Is on SaleBlackBerry Shifts Gears With Coretura Deal Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
